McLeod myopathy revisited: More neurogenic and less benign

Brain

Volumn 130, Issue 12, 2007, Pages 3285-3296

  Hewer, Ekkehard ^a   Danek, Adrian ^b   Schoser, Benedikt G ^c   Miranda, Marcelo ^d   Reichard, Ross ^e   Castiglioni, Claudia ^d   Oechsner, Matthias ^f   Goebel, Hans H ^a,g   Heppner, Frank L ^a   Jung, Hans H ^h  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b UNIVERSITY OF MUNICH   (Germany)

^c LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^d CLÍNICA LAS CONDES   (Chile)

^e UNIVERSITY OF NEW MEXICO   (United States)

^f Parkinson Klinik   (Germany)

^g JOHANNES GUTENBERG UNIVERSITY   (Germany)

^h UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Chorea; McLeod syndrome; Myopathy; Neuroacanthocytosis; Neuropathy

Indexed keywords

CREATINE KINASE;

ADULT; ARTICLE; AUTOPSY; CHOREA; CLINICAL ARTICLE; CONTROLLED STUDY; CREATINE KINASE BLOOD LEVEL; FOLLOW UP; GENETIC ANALYSIS; GRAND MAL SEIZURE; HEART DEATH; HEART FAILURE; HISTOLOGY; HUMAN; HUMAN TISSUE; HUNTINGTON CHOREA; HYPERTRANSLUCENT LUNG; MCLEOD NEUROACANTHOCYTOSIS SYNDROME; MENTAL DETERIORATION; MENTAL DISEASE; MOLECULAR GENETICS; MOTOR NERVE; MOTOR NEUROPATHY; MUSCLE ATROPHY; MUSCLE WEAKNESS; NEUROMUSCULAR DISEASE; PERSONALITY DISORDER; PNEUMONIA; PRIORITY JOURNAL; PSYCHOSIS; SCHIZOPHRENIA; SENSORY NERVE; SKELETAL MUSCLE; SYSTEMIC DISEASE; X CHROMOSOME LINKED DISORDER;

EID: 36749042063     PISSN: 00068950     EISSN: 14602156     Source Type: Journal    
DOI: 10.1093/brain/awm269     Document Type: Article

References (31)

1. Allen FH, Krabbe SMR, Corcoran PA. A new phenotype (McLeod) in the Kell blood-group system. Vox Sang 1961; 6: 555-60.
2. Barnett MH, Yang F, Iland H, Pollard JD. Unusual muscle pathology in McLeod syndrome. J Neurol Neurosurg Psychiatry 2000; 69: 655-7.
3. Brooke MH, Engel WK. The histographic analysis of human muscle biopsies with regard to fiber types. 1. Adult male and female. Neurology 1969; 19: 221-33.
4. Carter ND, Morgan JE, Monaco AP, Schwartz MS, Jeffery S. Dystrophin expression and genotypic analysis of two cases of benign X linked myopathy (McLeod's syndrome). J Med Genet 1990; 27: 345-7.
5. Danek A. Neuroacanthocytosis syndromes: what links red blood cells and neuron? In: Danek A, editor. Neuroacanthocytosis syndromes. Dordrecht: The Netherlands: Springer; 2004. p. 1-14.
6. Danek A, Jung HH, Melone MA, Rampoldi L, Broccoli V, Walker RH. Neuroacanthocytosis: new developments in a neglected group of dementing disorders. J Neurol Sci 2005; 229-30.
7. Danek A, Rubio JP, Rampoldi L, Ho M, Dobson-Stone C, Tison F, et al. McLeod neuroacanthocytosis: genotype and phenotype. Ann Neurol 2001; 50: 755-64.
8. Danek A, Witt TN, Stockmann HB, Weiss BJ, Schotland DL, Fischbeck KH. Normal dystrophin in McLeod myopathy. Ann Neurol 1990; 28: 720-722.
9. Dotti MT, Malandrini A, Federico A. Neuromuscular findings in eight Italian families with neuroacanthocytosis. In: Danek A, editor. Neuroacanthocytosis syndromes. Dordrecht: Springer; 2004. p. 127-38.
10. Francke U, Ochs HD, de Martinville B, Giacalone J, Lindgren V, Distèche C, et al. Minor Xp21 chromosome deletion in a male associated with expression of Duchenne muscular dystrophy, chronic granulomatous disease, retinitis pigmentosa, and McLeod syndrome. Am J Hum Genet 1985; 37: 250-67.
11. Giblett ER, Klebanoff SJ, Pincus SH. Kell phenotypes in chronic granulomatous disease: a potential transfusion hazard. Lancet 1971; 1: 1235-36.
12. Gil R, Toullat G, Pluchon C, Micheneau D, Cariou B, Rivault, et al. Une méthode d'évaluation rapide des fonctions cognitives (ERFC), son application à la démence sénile de type Alzheimer. Sem Hôp Paris 1986; 62: 2127-33.
13. Ho M, Chelly J, Carter N, Danek A, Crocker P, Monaco AP. Isolation of the gene for McLeod syndrome that encodes a novel membrane transport protein. Cell 1994; 77: 869-80.
14. Jung HH, Brandner S. Malignant McLeod myopathy. Muscle Nerve 2002; 26: 424-7.
15. Jung HH, Hergersberg M, Kneifel S, Alkadhi H, Schiess R, Weigell-Weber M, et al. McLeod syndrome: a novel mutation, predominant psychiatric manifestations, and distinct striatal imaging findings. Ann Neurol 2001a; 49: 384-92.
16. Jung HH, Russo D, Redman C, Brandner S. Kell and XK immunohistochemistry in McLeod myopathy. Muscle Nerve 2001b; 24: 1346-51.
17. Jung HH, Hergersberg M, Vogt M, Pahnke J, Treyer V, Röthlisberger B. McLeod phenotype associated with a XK missense mutation without hematological, neuromuscular, or cerebral involvement. Transfusion 2003; 43: 928-38.
18. Kawakami T, Takiyama Y, Sakoe K, Ogawa T, Yoshioka T, Nishizawa M, et al. A case of McLeod syndrome with unusually severe myopathy. J Neurol Sci 1999; 166: 36-39.
19. Lee S, Russo D, Redman CM. The Kell blood group system: Kell and XK membrane proteins. Semin Hematol 2000; 37: 113-21.
20. Malandrini A, Fabrizi GM, Truschi F, Di Pietro G, Moschini F, Bartalucci P, et al. Atypical McLeod syndrome manifested as X-linked chorea-acanthocytosis, neuromyopathy and dilated cardiomyopathy: report of a family. J Neurol Sci 1994; 124: 89-94.
21. Marsh WL, Marsh NJ, Moore A, Symmans WA, Johnson CL, Redman CM. Elevated serum creatine phosphokinase in subjects with McLeod syndrome. Vox Sang 1981; 40: 403-11.
22. Oechsner M, Danek A, Winkler G. McLeod-Neuroakanthozytose: Ein zu selten diagnostiziertes Syndrom? Akt Neurologie 1996; 23: 245-50.
23. Russo DC, Lee S, Reid ME, Redman CM. Point mutations causing the McLeod phenotype. Transfusion 2002; 42: 287-93.
24. Sorrentino G, De Renzo A, Miniello S, Nori O, Bonavita V. Late appearance of acanthocytes during the course of chorea-acanthocytosis. J Neurol Sci 1999; 163: 175-8.
25. Storch A, Kornhass M, Schwarz J. Testing for acanthocytosis. A prospective reader-blinded study in movement disorder patients. J Neurol 2005; 252: 84-90.
26. Swash M, Schwartz MS, Carter ND, Heath R, Leak M, Rogers KL. Benign X-linked myopathy with acanthocytes (McLeod syndrome). Its relationship to X-linked muscular dystrophy. Brain 1983; 106: 717-33.
27. Walker RH, Danek A, Uttner I, Offner R, Reid M, Lee S. McLeod phenotype without the McLeod syndrome. Transfusion 2007a; 47: 299-305.
28. Walker RH, Jung HH, Dobson-Stone C, Rampoldi L, Sano A, Tison F, et al. Neurologic phenotypes associated with acanthocytosis. Neurology 2007b; 68: 92-8.
29. Walker RH, Jung HH, Tison F, Lee S, Danek A. Phenotypic variation among brothers with the McLeod neuroacanthocytosis syndrome. Mov Disord 2007c; 22: 244-48.
30. Wimer BM, Marsh WL, Taswell HF, Galey WR. Haematological changes associated with the McLeod phenotype of the Kell blood group system. Br J Haematol 1977; 36: 219-24.
31. Witt TN, Danek A, Reiter M, Heim MU, Dirschinger J, Olsen EG. McLeod syndrome: a distinct form of neuroacanthocytosis. Report of two cases and literature review with emphasis on neuromuscular manifestations. J Neurol 1992; 239: 302-6.